title: Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.
abstract: Developing rational targeted cancer drugs requires the implementation of pharmacodynamic (PD), preferably non-invasive, biomarkers to aid response assessment and patient follow-up. Magnetic resonance spectroscopy (MRS) allows the non-invasive study of tumour metabolism. We describe the MRS-detectable PD biomarkers resulting from the action of targeted therapeutics, and discuss their biological significance and future translation into clinical use.
authors: Section of Magnetic Resonance, Cancer Research UK and EPSRC Cancer Imaging Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Surrey SM2 5PT, UK. mouniab@icr.ac.uk
authors: M
authors: M
authors: Beloueche-Babari
authors: Y-L
authors: YL
authors: Chung
authors: N M S
authors: NM
authors: Al-Saffar
authors: M
authors: M
authors: Falck-Miniotis
authors: M O
authors: MO
authors: Leach
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015415:Biomarkers; D002794:Choline / Q000378:metabolism; D016503:Drug Delivery Systems; D016903:Drug Monitoring / Q000379:methods*; D004734:Energy Metabolism / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006655:Histone Deacetylases / Q000378:metabolism; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D057170:Translational Research, Biomedical; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D023041:Xenograft Model Antitumor Assays
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D015415:Biomarkers; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D010743:Phospholipids; D011494:Protein Kinases; D006655:Histone Deacetylases; D002794:Choline